Selected research
Market Analysis & Forecast
Global Cyanocobalamin API Market Analysis and Forecast 2026-2032
Market perspective
The global Cyanocobalamin API market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Cyanocobalamin API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Cyanocobalamin API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Cyanocobalamin API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Cyanocobalamin API is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Cyanocobalamin API include Sanofi, Kingvit, North China Pharmaceutical Group, Hebei Yuxing Bio-Engineering, Hebei Huarong Pharmaceutical, GlaxoSmithKline, Wockhardt, Rochem International and EuroAPI, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Cyanocobalamin API, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Cyanocobalamin API, also provides the sales of main regions and countries. Of the upcoming market potential for Cyanocobalamin API, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cyanocobalamin API sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cyanocobalamin API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Cyanocobalamin API sales, projected growth trends, production technology, application and end-user industry.
Cyanocobalamin API Segment by Company
Sanofi
Kingvit
North China Pharmaceutical Group
Hebei Yuxing Bio-Engineering
Hebei Huarong Pharmaceutical
GlaxoSmithKline
Wockhardt
Rochem International
EuroAPI
Bristol Myers Squibb
Basic Nutrition
Antibiotice
Cyanocobalamin API Segment by Type
Crystal
Powder
Cyanocobalamin API Segment by Application
Contract Manufacturing Organizations
Pharmaceutical Companies
Others
Cyanocobalamin API Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyanocobalamin API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cyanocobalamin API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyanocobalamin API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Cyanocobalamin API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Cyanocobalamin API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cyanocobalamin API sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Crystal
- Powder
Applications
- Contract Manufacturing Organizations
- Pharmaceutical Companies
- Others
Companies covered
- Sanofi
- Kingvit
- North China Pharmaceutical Group
- Hebei Yuxing Bio-Engineering
- Hebei Huarong Pharmaceutical
- GlaxoSmithKline
- Wockhardt
- Rochem International
- EuroAPI
- Bristol Myers Squibb
- Basic Nutrition
- Antibiotice
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Cyanocobalamin API Market by Type
- 1.2.1 Global Cyanocobalamin API Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Crystal
- 1.2.3 Powder
- 1.3 Cyanocobalamin API Market by Application
- 1.3.1 Global Cyanocobalamin API Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Contract Manufacturing Organizations
- 1.3.3 Pharmaceutical Companies
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Cyanocobalamin API Market Dynamics
- 2.1 Cyanocobalamin API Industry Trends
- 2.2 Cyanocobalamin API Industry Drivers
- 2.3 Cyanocobalamin API Industry Opportunities and Challenges
- 2.4 Cyanocobalamin API Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Cyanocobalamin API Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Cyanocobalamin API Revenue by Region
- 3.2.1 Global Cyanocobalamin API Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Cyanocobalamin API Revenue by Region (2021-2026)
- 3.2.3 Global Cyanocobalamin API Revenue by Region (2027-2032)
- 3.2.4 Global Cyanocobalamin API Revenue Market Share by Region (2021-2032)
- 3.3 Global Cyanocobalamin API Sales Estimates and Forecasts 2021-2032
- 3.4 Global Cyanocobalamin API Sales by Region
- 3.4.1 Global Cyanocobalamin API Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Cyanocobalamin API Sales by Region (2021-2026)
- 3.4.3 Global Cyanocobalamin API Sales by Region (2027-2032)
- 3.4.4 Global Cyanocobalamin API Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Cyanocobalamin API Revenue by Manufacturers
- 4.1.1 Global Cyanocobalamin API Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Cyanocobalamin API Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Cyanocobalamin API Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Cyanocobalamin API Sales by Manufacturers
- 4.2.1 Global Cyanocobalamin API Sales by Manufacturers (2021-2026)
- 4.2.2 Global Cyanocobalamin API Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Cyanocobalamin API Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Cyanocobalamin API Sales Price by Manufacturers (2021-2026)
- 4.4 Global Cyanocobalamin API Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Cyanocobalamin API Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Cyanocobalamin API Manufacturers, Product Type & Application
- 4.7 Global Cyanocobalamin API Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Cyanocobalamin API Market CR5 and HHI
- 4.8.2 2025 Cyanocobalamin API Tier 1, Tier 2, and Tier 3
5 Cyanocobalamin API Market by Type
- 5.1 Global Cyanocobalamin API Revenue by Type
- 5.1.1 Global Cyanocobalamin API Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Cyanocobalamin API Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Cyanocobalamin API Revenue Market Share by Type (2021-2032)
- 5.2 Global Cyanocobalamin API Sales by Type
- 5.2.1 Global Cyanocobalamin API Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Cyanocobalamin API Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Cyanocobalamin API Sales Market Share by Type (2021-2032)
- 5.3 Global Cyanocobalamin API Price by Type
6 Cyanocobalamin API Market by Application
- 6.1 Global Cyanocobalamin API Revenue by Application
- 6.1.1 Global Cyanocobalamin API Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Cyanocobalamin API Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Cyanocobalamin API Revenue Market Share by Application (2021-2032)
- 6.2 Global Cyanocobalamin API Sales by Application
- 6.2.1 Global Cyanocobalamin API Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Cyanocobalamin API Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Cyanocobalamin API Sales Market Share by Application (2021-2032)
- 6.3 Global Cyanocobalamin API Price by Application
7 Company Profiles
- 7.1 Sanofi
- 7.1.1 Sanofi Company Information
- 7.1.2 Sanofi Business Overview
- 7.1.3 Sanofi Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Sanofi Cyanocobalamin API Product Portfolio
- 7.1.5 Sanofi Recent Developments
- 7.2 Kingvit
- 7.2.1 Kingvit Company Information
- 7.2.2 Kingvit Business Overview
- 7.2.3 Kingvit Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Kingvit Cyanocobalamin API Product Portfolio
- 7.2.5 Kingvit Recent Developments
- 7.3 North China Pharmaceutical Group
- 7.3.1 North China Pharmaceutical Group Company Information
- 7.3.2 North China Pharmaceutical Group Business Overview
- 7.3.3 North China Pharmaceutical Group Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 North China Pharmaceutical Group Cyanocobalamin API Product Portfolio
- 7.3.5 North China Pharmaceutical Group Recent Developments
- 7.4 Hebei Yuxing Bio-Engineering
- 7.4.1 Hebei Yuxing Bio-Engineering Company Information
- 7.4.2 Hebei Yuxing Bio-Engineering Business Overview
- 7.4.3 Hebei Yuxing Bio-Engineering Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Hebei Yuxing Bio-Engineering Cyanocobalamin API Product Portfolio
- 7.4.5 Hebei Yuxing Bio-Engineering Recent Developments
- 7.5 Hebei Huarong Pharmaceutical
- 7.5.1 Hebei Huarong Pharmaceutical Company Information
- 7.5.2 Hebei Huarong Pharmaceutical Business Overview
- 7.5.3 Hebei Huarong Pharmaceutical Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Hebei Huarong Pharmaceutical Cyanocobalamin API Product Portfolio
- 7.5.5 Hebei Huarong Pharmaceutical Recent Developments
- 7.6 GlaxoSmithKline
- 7.6.1 GlaxoSmithKline Company Information
- 7.6.2 GlaxoSmithKline Business Overview
- 7.6.3 GlaxoSmithKline Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 GlaxoSmithKline Cyanocobalamin API Product Portfolio
- 7.6.5 GlaxoSmithKline Recent Developments
- 7.7 Wockhardt
- 7.7.1 Wockhardt Company Information
- 7.7.2 Wockhardt Business Overview
- 7.7.3 Wockhardt Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Wockhardt Cyanocobalamin API Product Portfolio
- 7.7.5 Wockhardt Recent Developments
- 7.8 Rochem International
- 7.8.1 Rochem International Company Information
- 7.8.2 Rochem International Business Overview
- 7.8.3 Rochem International Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Rochem International Cyanocobalamin API Product Portfolio
- 7.8.5 Rochem International Recent Developments
- 7.9 EuroAPI
- 7.9.1 EuroAPI Company Information
- 7.9.2 EuroAPI Business Overview
- 7.9.3 EuroAPI Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 EuroAPI Cyanocobalamin API Product Portfolio
- 7.9.5 EuroAPI Recent Developments
- 7.10 Bristol Myers Squibb
- 7.10.1 Bristol Myers Squibb Company Information
- 7.10.2 Bristol Myers Squibb Business Overview
- 7.10.3 Bristol Myers Squibb Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Bristol Myers Squibb Cyanocobalamin API Product Portfolio
- 7.10.5 Bristol Myers Squibb Recent Developments
- 7.11 Basic Nutrition
- 7.11.1 Basic Nutrition Company Information
- 7.11.2 Basic Nutrition Business Overview
- 7.11.3 Basic Nutrition Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Basic Nutrition Cyanocobalamin API Product Portfolio
- 7.11.5 Basic Nutrition Recent Developments
- 7.12 Antibiotice
- 7.12.1 Antibiotice Company Information
- 7.12.2 Antibiotice Business Overview
- 7.12.3 Antibiotice Cyanocobalamin API Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 Antibiotice Cyanocobalamin API Product Portfolio
- 7.12.5 Antibiotice Recent Developments
8 North America
- 8.1 North America Cyanocobalamin API Market Size by Type
- 8.1.1 North America Cyanocobalamin API Revenue by Type (2021-2032)
- 8.1.2 North America Cyanocobalamin API Sales by Type (2021-2032)
- 8.1.3 North America Cyanocobalamin API Price by Type (2021-2032)
- 8.2 North America Cyanocobalamin API Market Size by Application
- 8.2.1 North America Cyanocobalamin API Revenue by Application (2021-2032)
- 8.2.2 North America Cyanocobalamin API Sales by Application (2021-2032)
- 8.2.3 North America Cyanocobalamin API Price by Application (2021-2032)
- 8.3 North America Cyanocobalamin API Market Size by Country
- 8.3.1 North America Cyanocobalamin API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Cyanocobalamin API Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Cyanocobalamin API Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Cyanocobalamin API Market Size by Type
- 9.1.1 Europe Cyanocobalamin API Revenue by Type (2021-2032)
- 9.1.2 Europe Cyanocobalamin API Sales by Type (2021-2032)
- 9.1.3 Europe Cyanocobalamin API Price by Type (2021-2032)
- 9.2 Europe Cyanocobalamin API Market Size by Application
- 9.2.1 Europe Cyanocobalamin API Revenue by Application (2021-2032)
- 9.2.2 Europe Cyanocobalamin API Sales by Application (2021-2032)
- 9.2.3 Europe Cyanocobalamin API Price by Application (2021-2032)
- 9.3 Europe Cyanocobalamin API Market Size by Country
- 9.3.1 Europe Cyanocobalamin API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Cyanocobalamin API Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Cyanocobalamin API Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
10 China
- 10.1 China Cyanocobalamin API Market Size by Type
- 10.1.1 China Cyanocobalamin API Revenue by Type (2021-2032)
- 10.1.2 China Cyanocobalamin API Sales by Type (2021-2032)
- 10.1.3 China Cyanocobalamin API Price by Type (2021-2032)
- 10.2 China Cyanocobalamin API Market Size by Application
- 10.2.1 China Cyanocobalamin API Revenue by Application (2021-2032)
- 10.2.2 China Cyanocobalamin API Sales by Application (2021-2032)
- 10.2.3 China Cyanocobalamin API Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Cyanocobalamin API Market Size by Type
- 11.1.1 Asia Cyanocobalamin API Revenue by Type (2021-2032)
- 11.1.2 Asia Cyanocobalamin API Sales by Type (2021-2032)
- 11.1.3 Asia Cyanocobalamin API Price by Type (2021-2032)
- 11.2 Asia Cyanocobalamin API Market Size by Application
- 11.2.1 Asia Cyanocobalamin API Revenue by Application (2021-2032)
- 11.2.2 Asia Cyanocobalamin API Sales by Application (2021-2032)
- 11.2.3 Asia Cyanocobalamin API Price by Application (2021-2032)
- 11.3 Asia Cyanocobalamin API Market Size by Country
- 11.3.1 Asia Cyanocobalamin API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Cyanocobalamin API Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Cyanocobalamin API Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Cyanocobalamin API Market Size by Type
- 12.1.1 SAMEA Cyanocobalamin API Revenue by Type (2021-2032)
- 12.1.2 SAMEA Cyanocobalamin API Sales by Type (2021-2032)
- 12.1.3 SAMEA Cyanocobalamin API Price by Type (2021-2032)
- 12.2 SAMEA Cyanocobalamin API Market Size by Application
- 12.2.1 SAMEA Cyanocobalamin API Revenue by Application (2021-2032)
- 12.2.2 SAMEA Cyanocobalamin API Sales by Application (2021-2032)
- 12.2.3 SAMEA Cyanocobalamin API Price by Application (2021-2032)
- 12.3 SAMEA Cyanocobalamin API Market Size by Country
- 12.3.1 SAMEA Cyanocobalamin API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Cyanocobalamin API Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Cyanocobalamin API Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Cyanocobalamin API Value Chain Analysis
- 13.1.1 Cyanocobalamin API Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Cyanocobalamin API Production Mode & Process
- 13.2 Cyanocobalamin API Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Cyanocobalamin API Distributors
- 13.2.3 Cyanocobalamin API Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst